Abstract
β-blokkers zijn bekende geneesmiddelen die voor diverse cardiovasculaire aandoeningen worden gebruikt (tabel 1). Het werkingsmechanisme berust op de blokkade van de β-adrenoreceptor.
This is a preview of subscription content, log in via an institution to check access.
Referenties
Cleland JG, McGowan J, Clark A, Freemantle N. The evidence for β-blockers in heart failure. Br Med J 1999; 318: 824–25.
Krotis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR. SHEP Collaborative Research Group. Long-term effect of diuretic based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005; 95: 29–35.
Mancia G, Grassi G, Zanchetti A. New-onset diabetes and antihypertensive drugs. J Hypertens 2006: 24: 3–10.
Author information
Authors and Affiliations
Copyright information
© 2009 Bohn Stafleu van Loghum
About this chapter
Cite this chapter
Baur, L.H.B. (2009). Is de combinatie bètablokker met AII-antagonist of ACE-remmer een zinnige combinatie?. In: Meest gestelde vragen over hypertensie. De meest gestelde vragen over: hypertensie. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-7340-6_15
Download citation
DOI: https://doi.org/10.1007/978-90-313-7340-6_15
Publisher Name: Bohn Stafleu van Loghum, Houten
Print ISBN: 978-90-313-7339-0
Online ISBN: 978-90-313-7340-6
eBook Packages: Dutch language eBook collection